thx to futundbiedl on flickr creative commons

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share it with others. That’s right. Send us your changes and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?

And here is our regular feature in which we highlight a different person each week. This time around, we note that Baxter International hired Jose Almeida as chief executive officer, effective Jan. 1. Previously, he was ceo at Covidien, which was recently sold to Medtronic for $50 billion. During his tenure there, he carved out the generic drug business to focus on devices and surgical tools.

Mylan hired Ranjan Ray Chaudhuri to as global commercial head of its over-the-counter business;

Roche moved Richard Erwin from Belgium to head its UK operations;

Bellicum Pharmaceuticals hired Alan Smith as senior vp of manufacturing;

Mirna Therapeutics hired Miguel Barbosa as exec vp and chief scientific officer;

Astellas promoted Doug Geiger to vp, head of new therapeutic areas, marketing strategy;

Aqua Pharmaceutical promoted Ted White to president and general manager;

BioTime promoted Adi Mohanty to co-chief executive officer;

Sorrento Therapeutics hired Jeffrey Sue as exec vp and chief operating officer;

Anika Therapeutics hired Richard Hague as chief commercial officer;

Trinity Partners added Nason Russ as a senior consultant;